Startseite Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease

  • Jens Lutz , Matthias Gorenflo , Matthias Habighorst , Martin Vogel , Peter E. Lange und Berthold Hocher
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 37 Heft 4

Abstract

Endothelin-1 (ET-1), with its vasoconstrictive and proliferation-stimulating effects, could play a role in the pathogenesis of primary pulmonary hypertension. We investigated the relationship between the ET-1 like immunoreactivity and the ET-receptor density, the grade of the pulmonary vasculopathy, and properties of the pulmonary circulation in patients with pulmonary hypertension due to congenital heart disease.

Twenty-six patients with a median age of 1 year and 1 month (6 weeks–17 years–9 months) were assigned to group I (n = 15) with a pulmonary to systemic flow ratio (Qp/Qs) ≥ 1.5 and a pulmonary to systemic resistance ratio (Rp/Rs) ≤ 0.3 (“high flow–low resistance group”) and to group II (n = 11) with a Qp/Qs < 1.5 and an Rp/Rs > 0.3 (“low flow–high resistance group”).

Patients belonging to group II showed a higher ETA-receptor density in lung arteries (p < 0.05) and parenchyma (p < 0.01) than patients in group I. Patients with the highest ET-1 like immunoreactivity in lung artery walls also showed a trend towards a higher ETA-receptor density. The ETB-receptor expression was low and not related to any of the above factors.

Our results suggest that the paracrine lung ET-1 system is up-regulated in pediatric patients with secondary pulmonary hypertension associated with congenital heart disease.

:
Published Online: 2005-06-01
Published in Print: 1999-04-01

Copyright (c)1999 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness
  2. Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review
  3. Improved Fluorescent PCR-Based Assay for Sizing CGG Repeats at the FRAXA Locus
  4. The Influence of Radiation and Chemotherapy-Related DNA Strand Breaks on Carcinogenesis: An Evaluation
  5. A Simple HPLC Method for Monitoring Mycophenolic Acid and Its Glucuronidated Metabolite in Transplant Recipients
  6. The Activities of Some Glycosaminoglycan-Degrading Enzymes in the Wall of the Umbilical Cord Artery and Their Alteration in Edema, Proteinuria, Hypertension (EPH)-Gestosis
  7. Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease
  8. Increased Serum Neopterin Concentrations in Patients with Alzheimer’s Disease
  9. Biomarkers of Bone Turnover and Bone Mineral Density in Hyperprolactinemic Amenorrheic Women
  10. Age Relationships and Sex Differences in Serum Levels of Pregnenolone and 17-Hydroxypregnenolone in Normal Subjects
  11. A Study of Hypermagnesaemia in a Hospital Population
  12. Multiple Regression Analysis of Interference Effects from a Hemoglobin-Based Oxygen Carrier Solution
  13. Serum Ionized Magnesium: Comparison of Results Obtained with Three Ion-Selective Analyzers
  14. Automated Prozone Effect Detection in Ferritin Homogeneous Immunoassays Using Neural Network Classifiers
  15. Recent Activities of EC4 in the Harmonization of Clinical Chemistry in the European Union
  16. Preventing Coronary Artery Disease. Cardioprotective Therapeutics in Practice. Edited by M. J. Kendall and R. C. Horton
  17. Will Medical Schools Remain what They Are? Medical Education in the Millennium. Edited by Brian Jolly and Lesley Rees
Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1999.069/html
Button zum nach oben scrollen